Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05564195
Other study ID # 2022-03593-01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 10, 2023
Est. completion date July 2024

Study information

Verified date April 2024
Source Karolinska Institutet
Contact Ulrica Nilsson, Professor
Phone 0046 8 524 838 22
Email ulrica.nilsson@ki.se
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Research problem and specific questions: Approximately 2.8 million surgeries are conducted yearly in Sweden and of these almost 50% are persons ≥ 60 years. Postoperative cognitive recovery is a concern for older persons. To date, there is no evidence for treating postoperative neurocognitive decline (POCD) and no assessment of cognitive function is routinely performed. The purpose is to is to test digital monitoring in clinical practice: I) test recruitment process and measure attrition rate; II) estimate the difference in main clinical outcomes (POCD) that will inform sample size calculations for the longitudinal observational mixed methods study, III) determine the usability and feasibility of digital monitoring. Participants: 50 patients ≥60 years undergoing inpatient surgery. Outcomes: depression, frailty, cognitive function, postoperative recovery and functional status .


Description:

The aim is to evaluate the digital cognitive monitoring (Mindmore-P) in clinical practice by: I) Test recruitment process and measure attrition rate. II) To establish whether it is possible to detect early signs of neurocognitive decline, using a digital postoperative cognitive screening tool i.e. Mindmore-P. III) To investigate if there are any associations between choice of anesthetic drugs, delirium, duration of anesthesia, preoperative frailty, depression symptoms, postoperative delirium, physical function, and early postoperative recovery. IV) Determine the usability and feasibility of Mindmore-P. V) Determine patients' experiences of early cognitive recovery in relation to signs of cognitive decline or no signs measured bythe four tests included in Mindmore-P METHODS AND ANALYSIS Study design This is an observational feasibility study. Participants included will be patients undergoing planned non-cardiac surgery with general anesthesia (n=50) at a hospital in Stockholm, Sweden. The sample size is based on the incidence of early cognitive decline at 1-2 weeks postoperatively of approximately 13-25%. Inclusion criteria: 1. >60 years of age undergoing elective non-cardiac surgery with general anesthesia. 2. Duration of surgery >60 minutes 3. Mini-mental state examination (MMSE) score >24. Exclusion criteria: 1. Unable to read and speak Swedish 2. Uncorrected severe visual or auditory disorder, disease of the central nervous system, psychiatric diseases including alcoholism or drug dependence, current motor impairment in dominant hand, or colour-blindness. Recruitment At the patient's preoperative anaesthesia consultation, a research nurse will provide oral and written information about the study. The details of the study and its potential benefits as well as risks will be explained carefully to the patient. If the patient agrees to participate in the study, they will undergo a MMSE screening to examine if they are eligible for the study. Outcomes, look below. Analysis Descriptive statistics of demographic data will be presented with number, percentage, and mean (sd) or min-max, as appropriate. As recommended by Borchers et al review from 2021, mild POCD (1-2 standard deviation [sd]) and major POCD (>2 sd) will be specified for each test result and POCD is present if at least two tests indicates decline. Usability and attrition rates will be presented with descriptive statistics. Preoperative depression (GDS), frailty (CFS), postoperative recovery (SwQoR), functional status (WHODAS) will be compared between the groups, using Kruskal Wallis ANOVA followed by Mann-Whitney U-test and a Bonferroni correction. To analyse intraindividual differences over time in cognitive performance, the same statistical tests will be used as well as multivariate logistic regression analysis. A p-value of <0.05 will be statistically significant in all analyses, Qualitative data will be analysed with thematic analysis.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date July 2024
Est. primary completion date July 2024
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: - >60 years of age undergoing elective non-cardiac surgery with general anesthesia. - Duration of surgery >60 minutes - Mini-mental state examination score >24. Exclusion Criteria: - Mini-mental state examination, cut-off score of <23 indicating cognitive impairment - Unable to read and speak Swedish - Uncorrected severe visual or auditory disorder, - Disease of the central nervous system - Psychiatric diseases - Alcoholism or drug dependence - Current motor impairment in dominant hand - Colour-blindness.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Postoperative cognitive function
Digital cognitive tests - Mindmore-P, will be used to assess neurocognitive capacity and includes tests of verbal episodic memory, executive functions, visuospatial function and attention. The cognitive tests are self-administered on a touch screen tablet (10.1" 20-30 min Windows). The Mindmore-P is a web-application running on a full-screen Chrome browser. The test is administered by using a capacitive touchscreen with features that record detailed information such as timing, pauses, and lifting of finger from the touchscreen. Speech recognition is used in the screening of verbal memory and language.

Locations

Country Name City State
Sweden Ulrica Nilsson Stockholm

Sponsors (2)

Lead Sponsor Collaborator
Karolinska Institutet Ersta Hospital, Sweden

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment process and attrition rate Number of possible participants vs. number of participants who accept to participate and number of participants who complete the study Through study completion, an average of 8 months
Primary Changes in postoperative cognitive function, part 1 Consortium to Establish a Registry for Alzheimer´s Disease (CERAD) A 10-word verbal learning test with 3 learning trials, a recall trial after ~7 min. Before surgery and day 1 or 2, and 3 weeks after surgery
Primary Changes in postoperative cognitive function, part 2 Trail Making Test (TMT- A & B), consisting of of 25 circles with letters or numbers on the screen.
4. Symbol Digits Processing Test (SDPT).The test consist of nine symbol-digit pairings at the top of the screen, one symbol in the middle of the screen, and a number grid at the bottom of the screen.
Before surgery and day 1 or 2, and 3 weeks after surgery
Primary Changes in postoperative cognitive function, part 3 Stroop Colour-Word Test (SCW). 24 words spelling out a the name of a colour which is printed in contrasting ink colours (e.g., the word "green" printed with red ink), and the participant is asked to tell the printed colour of the word rather than the word rather than the actual meaning of the word. Before surgery and day 1 or 2, and 3 weeks after surgery
Primary Changes in postoperative cognitive function, part 4 Symbol Digits Processing Test (SDPT).The test consist of nine symbol-digit pairings at the top of the screen, one symbol in the middle of the screen, and a number grid at the bottom of the screen. Before surgery and day 1 or 2, and 3 weeks after surgery
Secondary Frailty Clinical Frailty Scale, including 9-item ranging from 1 - very vital to 9 - terminally ill. Before surgery
Secondary Signs of and changes in depression Geriatric Depression Scale (GDS), consisting of 15 items to be answered with Yes or No. A score of 5 to 10 indicates probable depression and a score of more than 10 indicates definite depression. Before surgery and 3 weeks after surgery
Secondary Changes in functional capacity World Health Organization Disability Assessment Schedule 2.0 (WHODAS), thats consists of 12-item. Sum score ranges from 0-48, with increasing scores reflecting increasing disability Before surgery and 3 weeks after surgery
Secondary Changes in postoperative recovery Swedish version of Quality of Recovery, SwQoR, including 24 different postoperative symptoms to be rated on 11-point numerical scales from 0, "none of the time", to 10, "all of the time" Global score ranging from 0, "excellent quality of postoperative recovery," to 240, "extremely poor quality of recovery," with cutoff values of less than 31 at day 7 and less than 21 at day 14 indicating good recovery Before surgery and day 1 or 2, and 3 weeks after surgery
Secondary Usability of Mindmore-P System Usability Scale (SUS), consisting of 10 items to be answered on a 5-point scale from "strongly agree" to "strongly disagree". 3 weeks after surgery
Secondary Feasibility and patients' experiences of early postoperative cognitive recovery Semi-structured, one-on-one interviews exploring patients' experiences of being assessed for cognitive performance and using Mindmore-P including assessment of facilitators and barriers, will be conducted. The participants will be asked to communicate freely on their experiences of their postoperative recovery. One month after surgery
Secondary Signs of and changes in postoperative delirium Nursing Delirium Screening Scale NU-DESC, an observational five-item scale where symptoms delirium are rated from 0 to 2. A score of 2 or more indicates delirium After surgery twice a day on postoperative day 1-2
See also
  Status Clinical Trial Phase
Recruiting NCT05990790 - The Effect of Desflurane Versus Sevoflurane Versus Propofol on Postoperative Delirium Phase 4
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Active, not recruiting NCT02965235 - Correlations of Epigenetic Changes With POCD in Surgical Patients N/A
Not yet recruiting NCT02224443 - Effects of Different Doses of Dexmedetomidine on Postoperative Cognitive Dysfunction in Elderly Hypertensive Patients Phase 4
Recruiting NCT01934049 - Postoperative Recovery in Elderly Patients Undergoing Hip Hemi-arthroplasty Phase 4
Terminated NCT00991328 - Role of Absolute Cerebral Oximetry to Prevent Neurocognitive Injury in Elderly Patients Undergoing Cardiac Surgery Phase 3
Terminated NCT00757913 - n-3 Enriched Nutrition Therapy and Postoperative Cognitive Dysfunction After Cardiac Surgery Phase 4
Terminated NCT00455143 - Cognitive Protection - Dexmedetomidine and Cognitive Reserve Phase 4
Recruiting NCT06176144 - Impact of Desflurane and Sevoflurane on Postoperative Delirium in Elderly Patients N/A
Completed NCT03620968 - Implementation of a Cognitive Training Program to Reduce the Risk of Postoperative Cognitive Dysfunction N/A
Completed NCT04701801 - Correlation of Preoperative Anxiety With Early Postoperative Cognitive Dysfunction in Breast Cancer Patients
Not yet recruiting NCT06469515 - Older People's Neurocognitive Recovery After Cardiac Surgery
Not yet recruiting NCT02909413 - Comparison of Desflurane With Sevoflurane for School-age Children in Postoperative Cognitive Function N/A
Completed NCT02931877 - Comparison of Postoperative Outcome After Sevoflurane and Propofol Anaesthesia Phase 4
Completed NCT02650687 - Optimizing Postoperative Cognition the Elderly
Not yet recruiting NCT01622452 - Post Cardiac Surgery Neurocognitive Decline: Correlations Between Neuropsychological Tests and Functional MRI Techniques N/A
Completed NCT01103752 - Postoperative Cognitive Dysfunction After Total Knee or Hip Replacement Surgery in Fast-track Set-up N/A
Completed NCT04312516 - Greek Validation of ACE III Test in Perioperative Patients
Not yet recruiting NCT05668559 - Transcranial Magnetic Stimulation and Perioperative Neurocognitive Disorders N/A
Not yet recruiting NCT05439707 - Effects of Perioperative Transauricular Vagus Nerve Electrical Stimulation on POD, POCD and CPSP N/A